| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424558000 | Urogenital system (e.g., kidney, etc.) | 10 |
| 20090130221 | DECELLULARISATION OF TISSUE MATRICES FOR BLADDER IMPLANTATION - The invention provides an improved method of producing a natural, acellular matrix scaffold for subsequent use in tissue-engineered replacement of tissues such as the bladder. Decellularisation is carried out on an expanded or distended bladder and the product retains the strength and compliance of natural material. The invention also provides use of the matrix scaffolds as wound healing material and to investigate tissue structure and function in vitro. | 05-21-2009 |
| 20090297622 | SEPARATION AND FORMULATION OF BIOACTIVE FRACTION AND SUBFRACTION FROM CAMEL URINE WORK AS ANTICANCER AGENT - A pharmaceutical composition includes an effective amount of bio-active fraction PMF or subfraction PMFK obtained from the lyophilized camel urine or cow urine which coded in publications with PM701, that is used as anti-cancer drug selected from an anticancer compound PM701, which are targeted selectively the cancer cells without affecting the normal cells. | 12-03-2009 |
| 20130129834 | Compositions for Regenerating Defective or Absent Myocardium - Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function. | 05-23-2013 |
| 20150050359 | DECELLULARISATION OF TISSUE MATRICES FOR BLADDER IMPLANTATION - The invention provides an improved method of producing a natural, acellular matrix scaffold for subsequent use in tissue-engineered replacement of tissues such as the bladder. Decellularisation is carried out on an expanded or distended bladder and the product retains the strength and compliance of natural material. The invention also provides use of the matrix scaffolds as wound healing material and to investigate tissue structure and function in vitro. | 02-19-2015 |
| 20150335612 | Artemisinin And Its Derivatives For Use In The Treatment Of Kidney Disease - The present invention relates compounds according to Formula (I) wherein R | 11-26-2015 |
| 20160054336 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Clusterin, Heart-type fatty acid binding protein, Hepatocyte growth factor, Interferon gamma, Interleukin-12 subunit beta, Interleukin-16, Interleukin-2, 72 kDa type IV collagenase, Matrix metalloproteinase-9, Midkine, and Serum amyloid P-component as diagnostic and prognostic biomarkers in renal injuries. | 02-25-2016 |
| 424559000 | Genitalia (e.g., ovary, uterus, prostate, testis, etc.) | 1 |
| 20190142872 | FOLLICULAR FLUID | 05-16-2019 |
| 424561000 | Germ cell (e.g., ovum, spermatozoa, etc.) | 3 |
| 20100189803 | EJACULUM OF ANIMALS AS MEDICINAL MATERIAL AND USES THEREOF IN MEDICAMENTS FOR TREATMENT OF DISEASES SUCH AS TUMORS, DEPRESSION, ETC. - Provided are ejaculum of animals as medicinal materials and uses thereof in manufacture of medicaments for treatment of various tumors, depression, senile dementia, and dermatosis. Said tumors include ovarian cancer, uterine cancer, breast cancer, esophageal cancer, stomach cancer, colon cancer, lung cancer, osteocarcinama, etc. The present medicinal material, alone or in combination with additional agents, is similar to cyclophosphamide in antineoplastic effects, which is accepted presently the most potent chemotherapeutic agent. It can inhibit the growth of tumors, not destroying the normal immune system of human. The present medicinal material of ejaculum is powdery crystal prepared by vacuum lyophilization from fresh ejaculum of animals, and it is suitable to a variety of dosage forms such as capsule or oral solution. | 07-29-2010 |
| 20110020463 | THERAPEUTIC AGENT FOR FIBROMYALGIA SYNDROME AND THERAPEUTIC AGENT FOR PAIN CAUSED BY MUSCLE SPASM - A therapeutic agent for fibromyalgia syndrome or therapeutic agent for pain caused by vascular smooth muscle spasm including a) one or more compounds selected from a group consisting of RNA, ribonucleotide and ribonucleoside, b) one or more compounds selected from a group consisting of L-arginine, L-citrulline and L-ornithine, and c) L-ascorbic acid in which the mass ratio of Component b):Component c) is 1:0.2 to 20 is provided. | 01-27-2011 |
| 20130164382 | EJACULUM OF ANIMALS AS MEDICINAL MATERIAL AND USES THEREOF IN MEDICAMENTS FOR TREATMENT OF DISEASES SUCH AS TUMORS, DEPRESSION, ETC - Provided are ejaculum of animals as medicinal materials and uses thereof in manufacture of medicaments for treatment of various tumors, depression, senile dementia, and dermatosis. Said tumors include ovarian cancer, uterine cancer, breast cancer, esophageal cancer, stomach cancer, colon cancer, lung cancer, osteocarcinama, etc. The present medicinal material, alone or in combination with additional agents, is similar to cyclophosphamide in antineoplastic effects, which is accepted presently the most potent chemotherapeutic agent. It can inhibit the growth of tumors, not destroying the normal immune system of human. The present medicinal material of ejaculum is powdery crystal prepared by vacuum lyophilization from fresh ejaculum of animals, and it is suitable to a variety of dosage forms such as capsule or oral solution. | 06-27-2013 |
